scholarly article | Q13442814 |
P2093 | author name string | Schatzberg AF | |
Regier DA | |||
Rae DS | |||
Narrow WE | |||
Kaelber CT | |||
P433 | issue | 34 | |
P921 | main subject | comorbidity | Q1414874 |
P304 | page(s) | 24-28 | |
P577 | publication date | 1998-01-01 | |
P1433 | published in | The British journal of psychiatry. Supplement | Q27709593 |
P1476 | title | Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders |
Q35137665 | An examination of psychopathology and daily impairment in adolescents with social anxiety disorder |
Q44414523 | Anxiety and depression in the working population using the HAD Scale--psychometrics, prevalence and relationships with psychosocial work characteristics |
Q35924378 | Anxiety and depression: mouse genetics and pharmacological approaches to the role of GABA(A) receptor subtypes |
Q48689501 | Anxiety disorders and comorbid depression in community dwelling older adults. |
Q36857965 | Anxiety, depression and hopelessness in adolescents: a structural equation model |
Q55085940 | Anxiolytic effects of Lippia citriodora in a mouce model of anxiety. |
Q35020426 | Burden of anxiety disorders in pediatric medical settings: prevalence, phenomenology, and a research agenda |
Q92433255 | Cardiorespiratory Fitness Predicts Greater Vagal Autonomic Activity in Drug Users Under Stress |
Q36813492 | Co-morbid anxiety disorders in bipolar disorder and major depression: familial aggregation and clinical characteristics of co-morbid panic disorder, social phobia, specific phobia and obsessive-compulsive disorder |
Q55255406 | Cognitive Deficits Are Attenuated in Neuroglobin Overexpressing Mice Exposed to a Model of Obstructive Sleep Apnea. |
Q30973569 | Comparison of the estimated prevalence of mood and/or anxiety disorders in Canada between self-report and administrative data. |
Q35237009 | Core symptoms of major depressive disorder: relevance to diagnosis and treatment |
Q92251706 | Depressive symptoms are associated with blunted reward learning in social contexts |
Q36420660 | Design and Rationale for a Randomized Controlled Trial Testing the Efficacy of Aerobic Exercise for Patients with Obsessive-Compulsive Disorder |
Q91810751 | Differential Relationships of Child Anxiety and Depression to Child Report and Parent Report of Electronic Media Use |
Q37101257 | Distinct regions of prefrontal cortex mediate resistance and vulnerability to depression |
Q33959971 | Does fetal exposure to SSRIs or maternal depression impact infant growth? |
Q35835446 | Effect of age on the frequency of anxiety disorders in major depression with psychotic features |
Q37586106 | Effectiveness of a Cognitive Behavioral Therapy-Based Indicated Prevention Program for Children with Elevated Anxiety Levels: a Randomized Controlled Trial |
Q89900646 | Effects of repetitive gentle handling of male C57BL/6NCrl mice on comparative behavioural test results |
Q45986725 | Employment frustration and alcohol abuse/dependence among labor migrants in California |
Q90409515 | Examination of the Correlation Between Physical and Psychological Measures in Community-Dwelling Older Adults |
Q36531377 | Examining gender differences for gambling engagement and gambling problems among emerging adults |
Q44701365 | False beliefs: the current treatment of patients with depression |
Q35755235 | Frequency and patterns of psychiatric comorbidity in a sample of primary care patients with anxiety disorders |
Q34557801 | Genetic and environmental influences on the co-morbidity between depression, panic disorder, agoraphobia, and social phobia: a twin study |
Q36135959 | Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D. |
Q57395897 | Guided Internet-based cognitive behavioral therapy for mild and moderate depression: A benchmarking study |
Q37012607 | Hazardous drinking, depression, and anxiety among sexual-minority women: self-medication or impaired functioning? |
Q35996479 | High-fat diet transition reduces brain DHA levels associated with altered brain plasticity and behaviour |
Q38832608 | Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond |
Q36543425 | Integrating structural and epidemiological research to inform the classification of psychopathology |
Q35924435 | Intergenerational transmission of chronic physical disease via chronic mental disorders: the potential role of addictive behaviors |
Q36810167 | Lifetime comorbidities between phobic disorders and major depression in Japan: results from the World Mental Health Japan 2002-2004 Survey |
Q33684243 | Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers |
Q36901729 | Long-term use of benzodiazepines in participants with comorbid anxiety and alcohol use disorders |
Q24288801 | Major depression symptoms in primary care and psychiatric care settings: a cross-sectional analysis |
Q37235595 | Managing the patient with co-morbid depression and an anxiety disorder |
Q35914709 | Maternal drug abuse versus maternal depression: vulnerability and resilience among school-age and adolescent offspring |
Q36753076 | Meeting report: "Depression and Anxiety Spectrum disorders: from basic science to the clinic and back" |
Q37478347 | Meta-analysis comparing different behavioral treatments for late-life anxiety |
Q34075669 | Methyl donor-deficient diet during development can affect fear and anxiety in adulthood in C57BL/6J mice |
Q37586937 | Novelty-seeking behavior predicts vulnerability in a rodent model of depression |
Q36027999 | Parent psychopathology and youth internalizing symptoms in an urban community: a latent growth model analysis |
Q34229109 | Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D. |
Q39005115 | Potential Antidepressant Constituents of Nigella sativa Seeds. |
Q51944252 | Prevalence and correlates of mental disorders among Native American women in primary care. |
Q36238104 | Prevalence and functional consequences of severe insomnia symptoms in mood and anxiety disorders: results from a nationally representative sample |
Q54966434 | Prospective mental imagery as its link with anxiety and depression in prisoners. |
Q35905983 | Psychological and personality factors in type 2 diabetes mellitus, presenting the rationale and exploratory results from The Maastricht Study, a population-based cohort study. |
Q36836847 | Psychopathology of addiction: May a SCL-90-based five dimensions structure be applied irrespectively of the involved drug? |
Q46846893 | Qualitative changes in symptomatology as an effect of treatment with escitalopram in generalized anxiety disorder and major depressive disorder |
Q35663709 | Quality of life impairments among adults with social phobia: the impact of subtype |
Q37111333 | Refinement of diagnosis and disease classification in psychiatry |
Q34133400 | Reports of drinking to self-medicate anxiety symptoms: longitudinal assessment for subgroups of individuals with alcohol dependence |
Q36541539 | Screening for adolescent anxiety disorders in a pediatric emergency department |
Q34091656 | Social skills and social phobia: an investigation of DSM-IV subtypes |
Q36824896 | Substance use disorders in individuals with body dysmorphic disorder |
Q53402428 | The Effect of Gentle Handling on Depressive-Like Behavior in Adult Male Mice: Considerations for Human and Rodent Interactions in the Laboratory. |
Q64265959 | The Influence of Anxiety on the Recognition of Facial Emotion Depends on the Emotion Category and Race of the Target Faces |
Q90049232 | The Neuroscience of Drug Reward and Addiction |
Q48082503 | The chicken and egg of anxiety and depression. |
Q36246174 | The effects of mindfulness-based cognitive therapy on affective memory recall dynamics in depression: a mechanistic model of rumination |
Q33962590 | The elderly in the psychiatric emergency service (PES); a descriptive study |
Q33836454 | The expanding cognitive-behavioural therapy treatment umbrella for the anxiety disorders: disorder-specific and transdiagnostic approaches. |
Q34293707 | The influence of anxiety on the progression of disability |
Q43958257 | The long-term treatment outcomes of depression and anxiety comorbid with substance abuse |
Q33607241 | Toward the Identification of a Specific Psychopathology of Substance Use Disorders |
Q35166440 | Treatment of co-occurring anxiety disorders and substance use disorders |
Q34679817 | Using latent variable modeling and multiple imputation to calibrate rater bias in diagnosis assessment |
Search more.